Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

Sanwa Kagaku Kenkyusho Co., Ltd.

Overview

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Type 1 Diabetes Mellitus

Interventions

MiglitolDRUG

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type1 Diabetes * Criteria of postprandial glucose and HbA1c are met Exclusion Criteria: * Type2 Diabetes * Patients with antidiabetic drugs * The other exclusion criteria are met

Locations (7)

Unnamed facility

Chiba, Japan

Unnamed facility

Fukuoka, Japan

Unnamed facility

Gifu, Japan

Unnamed facility

Ibaraki, Japan

Unnamed facility

Kanagawa, Japan

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.